top of page

SUBSCRIBE TO OUR NEWSLETTER

THE LATEST NEWS IN CANCER CLINICAL RESEARCH

AT MEDSIR WE ARE DEDICATED TO OFFER THE MOST RELEVANT NEWS ON THE LATEST ADVANCEMENTS IN ONCOLOGY CLINICAL RESEARCH. FIND OUT THE LATEST NEWS ON ONCOLOGY RESEARCH, REGULATORY APPROVALS, EVENTS, SCIENTIFIC CONFERENCES AND MUCH MORE!

DOWNLOAD COMPANY DOSSIER

Search

Press Release: DEBBRAH Cohort 5 and ATRACTIB trial at San Antonio Breast Cancer Symposium

Dec 8, 20235 min read

Press Release: DEBBRAH Cohort 5 and ATRACTIB trial at San Antonio Breast Cancer Symposium

Press Release: PARSIFAL-LONG at San Antonio Breast Cancer Symposium

Dec 7, 20234 min read

Press Release: PARSIFAL-LONG at San Antonio Breast Cancer Symposium

Press Release: MiRaDor at San Antonio Breast Cancer Symposium

Dec 7, 20234 min read

Press Release: MiRaDor at San Antonio Breast Cancer Symposium

Join our presence at SABCS 2023

Nov 21, 20234 min read

Join our presence at SABCS 2023

The MEDSIR Oncoclínicas Academy: Elevating the potential in clinical research

Nov 15, 20233 min read

The MEDSIR Oncoclínicas Academy: Elevating the potential in clinical research

LUPER, focusing on Lung Cancer and two PHERGain's sub-studies, MEDSIR at ESMO 2023

Nov 3, 20234 min read

CANCER RESEARCH

LUPER, focusing on Lung Cancer and two PHERGain's sub-studies, MEDSIR at ESMO 2023

MEDSIR presents the results of three new studies at ESMO 2023: LUPER, focusing on lung cancer

Oct 31, 20237 min read

MEDSIR presents the results of three new studies at ESMO 2023: LUPER, focusing on lung cancer

Meet us at ESMO 2023

Oct 5, 20232 min read

Meet us at ESMO 2023

Beyond Chemotherapy: PHERGain Clinical Trial in HER2+ Early Breast Cancer

Oct 4, 20231 min read

Beyond Chemotherapy: PHERGain Clinical Trial in HER2+ Early Breast Cancer

Shaping the Future of Oncology in Latin America: 11º congresso Oncoclínica Dana-Farber

Oct 4, 20232 min read

Shaping the Future of Oncology in Latin America: 11º congresso Oncoclínica Dana-Farber

Spotlight – NOBROLA trial for advanced triple-negative breast cancer

Aug 3, 20233 min read

CANCER RESEARCH

Spotlight – NOBROLA trial for advanced triple-negative breast cancer

Phergain Collaborators’ Ecosystem in Spain.

Jul 20, 20236 min read

Phergain Collaborators’ Ecosystem in Spain.

Innovating Oncology Research: Unveiling Strategic Services for Success

Jul 12, 20232 min read

STRATEGIC SERVICES

Innovating Oncology Research: Unveiling Strategic Services for Success

Strategic Site Selection for Oncology Clinical Trials

Jun 23, 20233 min read

Strategic Site Selection for Oncology Clinical Trials

7 Challenges in Oncology Research That Benefit from Strategic Services

Jun 15, 20233 min read

STRATEGIC SERVICES

7 Challenges in Oncology Research That Benefit from Strategic Services

Advancing Oncology Care: MEDSIR at ASCO Annual Meeting

Jun 15, 20232 min read

Advancing Oncology Care: MEDSIR at ASCO Annual Meeting

MEDSIR at ASCO 2023

Jun 13, 202323 min read

MEDSIR at ASCO 2023

Strategic Services: Bridging the Gap Between Clinical Trials in Oncology Research

Jun 9, 20233 min read

Strategic Services: Bridging the Gap Between Clinical Trials in Oncology Research

MEDSIR Study Finds No Progression-Free Survival Benefit with Palbociclib Maintenance After First-Lin

Jun 6, 20233 min read

MEDSIR Study Finds No Progression-Free Survival Benefit with Palbociclib Maintenance After First-Lin

PALMIRA Study at ASCO 2023

Jun 5, 20232 min read

PALMIRA Study at ASCO 2023

PHERGain study at ASCO 2023

Jun 3, 20232 min read

PHERGain study at ASCO 2023

Revolutionizing Patient Care: MEDSIR's Hope for HER2-Positive Early Breast Cancer

Jun 2, 20234 min read

Revolutionizing Patient Care: MEDSIR's Hope for HER2-Positive Early Breast Cancer

Promising Advancements in Oncology Research Unveiled at ASCO Annual Meeting

May 31, 20233 min read

Promising Advancements in Oncology Research Unveiled at ASCO Annual Meeting

ESMO Breast Conference Recap: MEDSIR's Highlights from Berlin

May 30, 20232 min read

ESMO Breast Conference Recap: MEDSIR's Highlights from Berlin

2

3 4 5

bottom of page